Organon (OGN) Cost of Revenue (2020 - 2026)

Organon's Cost of Revenue history runs 7 years deep, the most recent figure standing at $677.0 million for Q1 2026.

• In Q1 2026, Cost of Revenue rose 0.74% year-over-year to $677.0 million; the TTM figure through Mar 2026 stood at $2.9 billion (up 7.9% YoY), while the FY2025 annual figure was $2.9 billion, up 8.0% from the prior year.
• Cost of Revenue was $677.0 million for Q1 2026 at Organon, down from $766.0 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $766.0 million in Q4 2025 to a low of $551.0 million in Q3 2022.
• Historically, Cost of Revenue has averaged $651.6 million across 5 years, with a median of $665.0 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Cost of Revenue slipped 9.52% in 2022, then grew 14.98% in 2023.
• A 5-year view of Cost of Revenue shows it stood at $594.0 million in 2022, then gained by 14.98% to $683.0 million in 2023, then gained by 1.9% to $696.0 million in 2024, then gained by 10.06% to $766.0 million in 2025, then declined by 11.62% to $677.0 million in 2026.
• The last three Cost of Revenue figures came in at $677.0 million (Q1 2026), $766.0 million (Q4 2025), and $745.0 million (Q3 2025), per Business Quant data.